| 000 | 01878 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515233448.0 | ||
| 264 | 0 | _c20101021 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1521-0103 | ||
| 024 | 7 |
_a10.1124/jpet.110.167965 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCai, Chun | |
| 245 | 0 | 0 |
_aProtection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198). _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cOct 2010 |
||
| 300 |
_a223-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAMP-Activated Protein Kinase Kinases |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xantagonists & inhibitors |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCalcium _xpharmacology |
| 650 | 0 | 4 |
_aCardiomyopathies _xchemically induced |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xanalogs & derivatives |
| 650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMass Spectrometry |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xbiosynthesis |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aPoly Adenosine Diphosphate Ribose _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase C-epsilon _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProtein Kinases _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 700 | 1 | _aLothstein, Leonard | |
| 700 | 1 | _aMorrison, R Ray | |
| 700 | 1 | _aHofmann, Polly A | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 335 _gno. 1 _gp. 223-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.110.167965 _zAvailable from publisher's website |
| 999 |
_c20007846 _d20007846 |
||